Real-time enrollment status for this b-cell non-hodgkin lymphoma-recurrent clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 4:32 AM UTC
| NCT Number | NCT06209619 |
| Recruiting Status | Recruiting |
| Condition | B-Cell Non-Hodgkin Lymphoma-Recurrent |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Nathan Denlinger |
| Last Updated on CT.gov | February 27, 2026 (Feb 27, 2026) |
As of July 21, 2026: Clinical trial NCT06209619 is currently recruiting participants. This phase1 study for b-cell non-hodgkin lymphoma-recurrent is actively seeking new participants at 1 location across the United States. The study is sponsored by Nathan Denlinger. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06209619 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06209619 was last updated Feb 27, 2026 (February 27, 2026). HelloStudys verifies this status automatically.